Retrospective observational study reveals D-Dimer's limited diagnostic value in myocardial infarction and unstable angina.
Background: D-dimer is a fibrin degradation product formed during fibrinolysis and reflects the activation of coagulation and fibrinolytic pathways. The role of D-dimer in acute coronary syndrome (ACS) remains uncertain. This study was designed to analyse differences in D-dimer levels in patients with different forms of ACS and the diagnostic efficiency and possible complementary role of the D-dimer biomarker. Methods: This study applied a retrospective observational design and included adult patients presenting to the emergency department with chest pain. Differences in D-dimer levels across diagnostic categories were analysed. To evaluate the diagnostic performance of D-dimer, receiver operating characteristic (ROC) analysis was conducted, which involved calculations of area under the curve (AUC), sensitivity, specificity, and likelihood ratios. Also, the incremental value of D-dimer over clinical data and cardiac troponin was determined through a multivariate logistic regression model. Results: The study found that the level of D-dimer was significantly higher in patients with ST elevation myocardial infarction (STEMI) and Non-ST elevation myocardial infarction (NSTEMI) compared to patients with unstable angina (UA) and non-specific chest pain (p < 0.001). As per ROC analysis, the level of D-dimer demonstrated modest discrimination between STEMI/NSTEMI and unstable angina (AUC 0.618; 95% CI 0.538– 0.697), and a fair discrimination between STEMI/NSTEMI and non-specific chest pain (AUC 0.668; 95% CI 0.601– 0.736). At a cutoff of 0.50 mg/L, sensitivity and specificity were limited. In multivariable models, D-dimer did not provide incremental diagnostic value beyond clinical variables and cardiac troponin (ΔAUC not significant). Conclusion: Despite higher D-dimer concentrations in myocardial infarction, the marker exhibited modest diagnostic performance and did not provide additional diagnostic value over cardiac troponin. Therefore, D-dimer is suggested to be used as an adjunct rather than primary diagnostic instrument in patients presenting with suspected acute coronary syndrome.
No takes yet. Share an insight, caveat, or question.
Alsuleiman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: